Corporate news

Media contacts:

T: +44(0) 1895 826 654

T: +44(0) 1895 826 227

contact@norgine.com

Corporate news items are intended for business/trade media and for analysts/investors.

Norgine B.V. celebrates 30 years of the bowel preparations used in colonoscopy to help prevent and diagnose gastrointestinal diseases, including colorectal cancer
04 October 2021
Read media release
New data in the European Heart Journal show ciraparantag reverses the anticoagulant activity of apixaban and rivaroxaban in elderly patients
03 October 2021
Read media release
Norgine B.V. and US WorldMeds enter into exclusive licensing agreement to commercialise DFMO (eflornithine) in Europe, Commonwealth of Independent States, Australia and New Zealand
22 July 2021
Read media release
Norgine B.V. enters into exclusive distribution agreement for the commercialisation of PLENVU^® in China with Beijing Podconley Pharmaceutical Technology & Development Co., Ltd.
15 June 2021
Read media release

Access corporate news archive